Chevy Chase Trust Holdings, Inc. Edwards Lifesciences Corp Transaction History

Chevy Chase Trust Holdings, Inc.

$32.3 Billion
Q3 2024

A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 330,393 shares of EW stock, worth $24.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

330,393

Previous 333,855 1.04%

Holding current value

$24.5 Million

Previous $30.8 Million 29.3%

% of portfolio

0.07%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $206,681 - $324,666	-3,462 Reduced 1.04%	330,393 $21.8 Million
Q2 2024 Jul 22, 2024	SELL	$84.3 - $94.31 $745,127 - $833,606	-8,839 Reduced 2.58%	333,855 $30.8 Million
Q1 2024 May 03, 2024	SELL	$72.54 - $95.56 $214,645 - $282,762	-2,959 Reduced 0.86%	342,694 $32.7 Million
Q4 2023 Jan 24, 2024	SELL	$61.71 - $77.76 $146,869 - $185,068	-2,380 Reduced 0.68%	345,653 $26.4 Million
Q3 2023 Oct 23, 2023	SELL	$69.28 - $93.38 $493,065 - $664,585	-7,117 Reduced 2.0%	348,033 $24.1 Million
Q2 2023 Jul 25, 2023	SELL	$81.41 - $94.33 $857,898 - $994,049	-10,538 Reduced 2.88%	355,150 $33.5 Million
Q1 2023 May 17, 2023	BUY	$74.26 - $84.51 $27.2 Million - $30.9 Million	365,688 New	365,688 $30.3 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $1.57 Million - $2.01 Million	-22,935 Reduced 5.95%	362,271 $27 Million
Q3 2022 Nov 04, 2022	BUY	$82.37 - $107.29 $167,622 - $218,335	2,035 Added 0.53%	385,206 $31.8 Million
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $28,891 - $42,842	334 Added 0.09%	383,171 $36.4 Million
Q1 2022 Apr 27, 2022	BUY	$101.96 - $128.34 $98,187 - $123,591	963 Added 0.25%	382,837 $45.1 Million
Q4 2021 Jan 31, 2022	SELL	$106.37 - $130.68 $979,880 - $1.2 Million	-9,212 Reduced 2.36%	381,874 $49.5 Million
Q3 2021 Oct 20, 2021	SELL	$102.91 - $122.75 $1.38 Million - $1.64 Million	-13,398 Reduced 3.31%	391,086 $44.3 Million
Q2 2021 Jul 20, 2021	SELL	$83.84 - $104.76 $1.92 Million - $2.4 Million	-22,943 Reduced 5.37%	404,484 $41.9 Million
Q1 2021 Apr 22, 2021	SELL	$78.68 - $90.67 $2.77 Million - $3.19 Million	-35,174 Reduced 7.6%	427,427 $35.8 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $666,358 - $847,982	-9,295 Reduced 1.97%	462,601 $42.2 Million
Q3 2020 Nov 06, 2020	SELL	$67.19 - $87.44 $2.54 Million - $3.31 Million	-37,802 Reduced 7.42%	471,896 $37.7 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $18.9 Million - $25.3 Million	328,759 Added 181.7%	509,698 $35.2 Million
Q1 2020 May 13, 2020	BUY	$52.41 - $81.0 $155,919 - $240,975	2,975 Added 1.67%	180,939 $34.1 Million
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $67,684 - $77,492	944 Added 0.53%	177,964 $13.8 Million
Q3 2019 Nov 20, 2019	SELL	$61.55 - $75.43 $23,204 - $28,437	-377 Reduced 0.21%	177,020 $13 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $30,378 - $35,103	545 Added 0.31%	177,397 $32.8 Million
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $50,380 - $67,380	1,052 Added 0.6%	176,852 $31.2 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $64,231 - $78,804	-1,384 Reduced 0.78%	175,800 $26.9 Million
Q3 2018 Oct 23, 2018	SELL	$45.7 - $58.03 $256,514 - $325,722	-5,613 Reduced 3.07%	177,184 $30.8 Million
Q2 2018 Aug 02, 2018	SELL	$42.45 - $51.3 $4,924 - $5,950	-116 Reduced 0.06%	182,797 $26.6 Million
Q1 2018 Apr 10, 2018	SELL	$37.19 - $47.45 $248,615 - $317,203	-6,685 Reduced 3.53%	182,913 $25.5 Million
Q4 2017 Jan 22, 2018	SELL	$33.79 - $39.39 $6,453 - $7,523	-191 Reduced 0.1%	189,598 $21.4 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $6.89 Million - $7.37 Million	189,789	189,789 $20.7 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.

Account

Chevy Chase Trust Holdings, Inc. Edwards Lifesciences Corp Transaction History